Vimentin is a target of PKCβ phosphorylation in MCP-1-activated primary human monocytes

[1]  M. Febbraio,et al.  Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1. , 2013, Cardiovascular research.

[2]  M. Irwin,et al.  PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. , 2012, Clinical science.

[3]  S. Kunapuli,et al.  Protein kinase C - possible therapeutic target to treat cardiovascular diseases. , 2010, Cardiovascular & hematological disorders drug targets.

[4]  C. Rommel,et al.  Leukocyte transmigration is modulated by chemokine‐mediated PI3Kγ‐dependent phosphorylation of vimentin , 2009, European journal of immunology.

[5]  Y. Zou,et al.  Mice deficient in PKC β and apolipoprotein E display decreased atherosclerosis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  R. Barker,et al.  Macrophages: promising targets for the treatment of atherosclerosis. , 2009, Current vascular pharmacology.

[7]  H. Leong,et al.  Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. , 2007, The American journal of pathology.

[8]  M. Andrassy,et al.  Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis. , 2006, Journal of the American College of Cardiology.

[9]  S. Jalkanen,et al.  Vimentin function in lymphocyte adhesion and transcellular migration , 2006, Nature Cell Biology.

[10]  P. Ferrara,et al.  SC5 mAb Represents a Unique Tool for the Detection of Extracellular Vimentin as a Specific Marker of Sézary Cells1 , 2006, The Journal of Immunology.

[11]  M. Inagaki,et al.  PKCε‐mediated phosphorylation of vimentin controls integrin recycling and motility , 2005 .

[12]  G. King,et al.  Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[13]  D. Markovitz,et al.  The Endothelial Cell-Specific Antibody PAL-E Identifies a Secreted Form of Vimentin in the Blood Vasculature , 2004, Molecular and Cellular Biology.

[14]  M. Andrassy,et al.  PKCβ regulates ischemia/reperfusion injury in the lung , 2004 .

[15]  Y. Zou,et al.  Early Growth Response-1 Promotes Atherogenesis: Mice Deficient in Early Growth Response-1 and Apolipoprotein E Display Decreased Atherosclerosis and Vascular Inflammation , 2004, Circulation research.

[16]  M. Kinter,et al.  Proteomic Analysis of Oxidative Stress-resistant Cells , 2004, Molecular & Cellular Proteomics.

[17]  N. Hu,et al.  Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer , 2004, Oncogene.

[18]  D. Xie,et al.  Association of Vimentin overexpression and hepatocellular carcinoma metastasis , 2004, Oncogene.

[19]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[20]  B. Osterud,et al.  Role of monocytes in atherogenesis. , 2003, Physiological reviews.

[21]  M. Cathcart,et al.  Protein Kinase C β Is Required for Human Monocyte Chemotaxis to MCP-1* , 2003, Journal of Biological Chemistry.

[22]  Wayne F. Patton,et al.  Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology , 2003, Proteomics.

[23]  M J Brown,et al.  Rigidity of Circulating Lymphocytes Is Primarily Conferred by Vimentin Intermediate Filaments , 2001, The Journal of Immunology.

[24]  N. Sherman,et al.  Protein Sequencing and Identification Using Tandem Mass Spectrometry: Kinter/Tandem Mass Spectrometry , 2000 .

[25]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[26]  P. Matsudaira,et al.  Integrating the Actin and Vimentin Cytoskeletons , 1999, The Journal of cell biology.

[27]  D. Ingber,et al.  Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. , 1998, Journal of cell science.

[28]  A. Sica,et al.  Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. , 1998, Journal of immunology.

[29]  C. Martínez-A,et al.  Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[31]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Foidart,et al.  VIMENTIN EXPRESSION IN CERVICAL CARCINOMAS: ASSOCIATION WITH INVASIVE AND MIGRATORY POTENTIAL , 1996, The Journal of pathology.

[33]  J. Lord,et al.  Protein Kinase C-δ Associates with Vimentin Intermediate Filaments in Differentiated HL60 Cells , 1996 .

[34]  L. Jahn,et al.  Fibrinogen promotes monocyte adhesion via a protein kinase C dependent mechanism , 1996, Journal of Molecular Medicine.

[35]  P. Allavena,et al.  Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein‐1 and related chemokines , 1995, Journal of leukocyte biology.

[36]  S Chien,et al.  Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Raymond B. Runyan,et al.  Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Marmur,et al.  Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury. , 1992, Circulation.

[39]  Jeffrey M. Skerker,et al.  Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. , 1992, Cancer research.

[40]  K. Murti,et al.  Protein kinase C associates with intermediate filaments and stress fibers. , 1992, Experimental cell research.

[41]  A. J. Valente,et al.  Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Aller,et al.  Vimentin expression as a late event in the in vitro differentiation of human promonocytic cells. , 1992, Journal of cell science.

[43]  A. Mantovani,et al.  The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. , 1991, Journal of immunology.

[44]  R M Nerem,et al.  The pathogenesis of atherosclerosis: An overview , 1991, Clinical cardiology.

[45]  Leonard,et al.  Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. , 1990, The American journal of pathology.

[46]  M. Territo,et al.  Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. , 1990, The Journal of clinical investigation.

[47]  B. Rollins,et al.  The human homolog of the JE gene encodes a monocyte secretory protein , 1989, Molecular and cellular biology.

[48]  K. Weber,et al.  Phosphorylation in vitro of vimentin by protein kinases A and C is restricted to the head domain. Identification of the phosphoserine sites and their influence on filament formation. , 1989, European journal of biochemistry.

[49]  R. Strieter,et al.  Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. , 1989, Biochemical and biophysical research communications.

[50]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[51]  W. Franke,et al.  Expression of intermediate filament proteins during development of Xenopus laevis. I. cDNA clones encoding different forms of vimentin. , 1989, Development.

[52]  C. Huang,et al.  Vimentin, a cytoskeletal substrate of protein kinase C. , 1988, Biochemical and biophysical research communications.

[53]  D. Morel,et al.  Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic , 1985, Journal of leukocyte biology.

[54]  E. Lazarides,et al.  Phosphorylation of intermediate filament proteins by cAMP-dependent protein kinases , 1981, Cell.

[55]  S. Hinuma,et al.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation. , 1979, Journal of immunological methods.

[56]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[57]  D. Spandau,et al.  Expression of vimentin in cultured human keratinocytes is associated with cell—extracellular matrix junctions , 2006, Archives of Dermatological Research.

[58]  M. Inagaki,et al.  PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility. , 2005, The EMBO journal.

[59]  M. Andrassy,et al.  PKCbeta regulates ischemia/reperfusion injury in the lung. , 2004, The Journal of clinical investigation.

[60]  M. Cathcart,et al.  Protein kinase C beta is required for human monocyte chemotaxis to MCP-1. , 2003, The Journal of biological chemistry.

[61]  D. Markovitz,et al.  Vimentin is secreted by activated macrophages , 2003, Nature Cell Biology.

[62]  F. W. Flitney,et al.  Structure and function of a vimentin-associated matrix adhesion in endothelial cells. , 2001, Molecular biology of the cell.

[63]  J. Lord,et al.  Protein kinase C-delta associates with vimentin intermediate filaments in differentiated HL60 cells. , 1996, Experimental cell research.

[64]  M. Burdick,et al.  Interferon-γ Stimulates Monocyte Chemotactic Protein-1 Expression by Monocytes , 1994, Mediators of inflammation.

[65]  L. Stryer,et al.  Association of the beta isoform of protein kinase C with vimentin filaments. , 1992, Cell motility and the cytoskeleton.

[66]  L. Stryer,et al.  Association of the β isoform of protein kinase C with vimentin filaments , 1992 .